Department of Public Health Sciences, Miller School of Medicine, University of Miami, 1120 NW 14th St, Miami, FL, 33136, USA.
Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL, USA.
Harm Reduct J. 2021 Nov 19;18(1):116. doi: 10.1186/s12954-021-00563-8.
Syringe services programs (SSPs) remain highly effective, cost-saving interventions for the prevention of blood-borne infections among people who inject drugs. However, there have been restrictions regarding financial resources allocated to these programs, particularly in the US South. This study aimed to provide cost data regarding the implementation and first-year operations of an academic-based SSP utilizing fixed and mobile strategies, including the integration of onsite wound care.
We conducted a micro-costing study that retrospectively collected detailed resource utilization and unit cost data for both the fixed and mobile SSP strategies, including onsite wound care, from both healthcare and societal perspectives. A three-step approach was used to identify, measure, and value intervention costs, and cost components were categorized into implementation, variable program, and time-dependent costs. Sensitivity analysis was performed to examine the impact of SSP operational changes (i.e., needs-based distribution and opt-out HIV/HCV testing) on the cost-per-participant. Cost data we presented as overall cost and cost-per-participant adjusted to 2017 US dollars.
A total of 452 and 129 participants enrolled in fixed and mobile SSP services, respectively. The total cost associated with implementation and first year operations for the fixed site was $407,217.22 or $729.72 per participant and $311,625.52 or $2415.70 per participant for the mobile unit. The largest cost component for both modalities was time-dependent costs (personnel and overhead), while intervention materials (syringes, injection equipment, naloxone) were less than 15% of the total program cost.
DISCUSSION/CONCLUSION: Implementation and operation of new SSP models continue to be low cost compared to treatment for the multitude of harms PWID face without access to evidence-based prevention. Future cost-effectiveness and cost-benefit analyses integrating a comprehensive SSP model within an academic institution, including onsite wound care and other medical services, will provide a more comprehensive understanding of this model, and state-level policy action must be taken to lift the prohibition of state and local funds for the implementation, sustainability, and maintenance of these programs in Florida.
注射器服务项目(SSP)仍然是预防吸毒者血液传播感染的非常有效且节省成本的干预措施。然而,用于这些项目的财政资源一直受到限制,特别是在美国南部。本研究旨在提供关于利用固定和移动策略(包括现场伤口护理)实施和运营第一年的学术性 SSP 的成本数据,包括现场伤口护理。
我们进行了微观成本研究,从医疗保健和社会角度回顾性地收集了固定和移动 SSP 策略(包括现场伤口护理)的详细资源利用和单位成本数据。使用三步法确定、衡量和评估干预成本,将成本构成分为实施、可变计划和时间相关成本。进行敏感性分析以检查 SSP 运营变化(即基于需求的分配和选择退出 HIV/HCV 检测)对每位参与者成本的影响。我们以每位参与者的总成本和调整至 2017 年的美元成本来呈现成本数据。
固定和移动 SSP 服务分别有 452 名和 129 名参与者入组。固定地点的实施和第一年运营总成本为 407217.22 美元,或每位参与者 729.72 美元,移动单位为 311625.52 美元,或每位参与者 2415.70 美元。两种模式最大的成本构成是时间相关成本(人员和间接费用),而干预材料(注射器、注射设备、纳洛酮)不到项目总成本的 15%。
讨论/结论:与未经循证预防而面临多种危害的吸毒者的治疗相比,新 SSP 模型的实施和运营成本仍然较低。未来的成本效益和成本效益分析将在学术机构内整合全面的 SSP 模型,包括现场伤口护理和其他医疗服务,将更全面地了解这种模式,并且必须采取州级政策行动,取消佛罗里达州对实施、可持续性和维护这些计划的州和地方资金的禁令。